Sentek Pty Ltd – Trademark Portfolio

Entity Type: 82

Sentek Pty Ltd holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 12 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 4 trademarks are registered and 2 are pending. Notable registered marks include SENTEK, DIVINER, IRRIMAX, and TRISCAN.

77 Magill Road

STEPNEY SA 5069

12 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Sentek Pty Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (12 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Sentek Pty Ltd have?

Sentek Pty Ltd has 12 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 pending, 1 abandoned, 3 cancelled.

What trademark classes does Sentek Pty Ltd file in?

Sentek Pty Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Sentek Pty Ltd's most well-known trademarks?

Sentek Pty Ltd's registered trademark portfolio includes well-known marks such as SENTEK, DIVINER, IRRIMAX, and TRISCAN. These are among 4 currently registered trademarks in the portfolio.

What is Sentek Pty Ltd's trademark registration success rate?

Sentek Pty Ltd has a 50% trademark registration rate, with 4 out of 8 resolved applications resulting in successful registration. Currently, 2 applications are pending review.